A Dose-Ranging Study of JNJ-40411813 in Healthy Male Volunteers

NCT01358006 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: JNJ-40411813
DRUG: JNJ-40411813

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.